[{"address1": "120 Newport Center Drive", "address2": "Suite 250", "city": "Newport Beach", "state": "CA", "zip": "92660", "country": "United States", "phone": "866-794-4940", "website": "https://elevaiskincare.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. Graydon  Bensler C.F.A.", "age": 31, "title": "CEO, CFO, Secretary & Director", "yearBorn": 1992, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hatem  Abou-Sayed F.A.C.S., FACS, M.B.A., M.D., MBA", "age": 51, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5623, "open": 0.56, "dayLow": 0.54, "dayHigh": 0.565, "regularMarketPreviousClose": 0.5623, "regularMarketOpen": 0.56, "regularMarketDayLow": 0.54, "regularMarketDayHigh": 0.565, "volume": 66159, "regularMarketVolume": 66159, "averageVolume": 163680, "averageVolume10days": 59120, "averageDailyVolume10Day": 59120, "marketCap": 10239518, "fiftyTwoWeekLow": 0.54, "fiftyTwoWeekHigh": 4.244, "priceToSalesTrailing12Months": 4.6876984, "fiftyDayAverage": 0.63252, "twoHundredDayAverage": 1.0409114, "currency": "USD", "enterpriseValue": 9453259, "profitMargins": -2.11417, "floatShares": 6698388, "sharesOutstanding": 18892100, "sharesShort": 76568, "sharesShortPriorMonth": 145521, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0041, "heldPercentInsiders": 0.80303, "heldPercentInstitutions": 0.00285, "shortRatio": 0.78, "shortPercentOfFloat": 0.0085, "impliedSharesOutstanding": 19554400, "bookValue": 0.143, "priceToBook": 3.7902095, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -4618071, "trailingEps": -0.37, "enterpriseToRevenue": 4.328, "enterpriseToEbitda": -2.14, "52WeekChange": -0.8405882, "SandP52WeekChange": 0.24919295, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ELAB", "underlyingSymbol": "ELAB", "shortName": "Elevai Labs, Inc.", "longName": "Elevai Labs Inc.", "firstTradeDateEpochUtc": 1700577000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5c695af1-36eb-364e-86db-fbf1f5ae6ba9", "messageBoardId": "finmb_1683617420", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.542, "recommendationKey": "none", "totalCash": 962046, "totalCashPerShare": 0.051, "ebitda": -4416401, "totalDebt": 175779, "quickRatio": 0.832, "currentRatio": 2.57, "totalRevenue": 2184338, "debtToEquity": 7.07, "revenuePerShare": 0.173, "returnOnAssets": -0.87781996, "returnOnEquity": -2.7167199, "freeCashflow": -3724688, "operatingCashflow": -5995373, "revenueGrowth": 3.303, "grossMargins": 0.6784, "ebitdaMargins": -2.0218499, "operatingMargins": -2.57854, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-11"}]